
Pseudomonas aeruginosa, in spite of being an ubiquitous microorganism, rarely colonizes healthy individuals. Hospitalization, as well as the length of time spent in hospital, significantly increase the rate of colonization, especially in immunocompromized patients. Antibacterial chemotherapy or prophylaxis together with invasive diagnostic procedures favour colonization and infection with P. aeruginosa. Immune deficiencies and adverse interactions of P. aeruginosa with the immune system facilitate infection. Thus, a number of exogenous as well as endogenous factors and their interactions favour infection of patients with P. aeruginosa.
Cross Infection, Virulence, Immunologic Deficiency Syndromes, Drug Resistance, Microbial, Opportunistic Infections, Prognosis, Anti-Bacterial Agents, Sepsis, Pseudomonas aeruginosa, Immune Tolerance, Humans, Pseudomonas Infections
Cross Infection, Virulence, Immunologic Deficiency Syndromes, Drug Resistance, Microbial, Opportunistic Infections, Prognosis, Anti-Bacterial Agents, Sepsis, Pseudomonas aeruginosa, Immune Tolerance, Humans, Pseudomonas Infections
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
